SEC-sourced researchBeta

NIVF

NewGenIvf Group Ltd

US markets

Data passport

CIK: 0001981662
Exchange: Nasdaq
Business activity: — · SIC 8090
Financial inputs: 6/6
Filing date: Oct 7, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 9:09 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

NIVF · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2023	5,136,153.0000	Mar 31, 2026
December 2024	5,433,375.0000	Mar 31, 2026
December 2025	4,726,433.0000	Mar 31, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	4,726,433.0000	9,879,408.0000	-10,926,056.0000	32,722,769.0000	6,736,076.0000	Mar 31, 2026
December 2024	5,433,375.0000	-524,643.0000	-8,264,074.0000	3,577,744.0000	5,059,501.0000	Mar 31, 2026
December 2023	5,136,153.0000	130,193.0000	-1,766,135.0000	—	—	Mar 31, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenues	$4.73M	December 2025	Mar 31, 2026	20-F
Previous period revenueRevenues	$5.43M	December 2024	Mar 31, 2026	20-F
Net incomeNetIncomeLoss	$9.88M	December 2025	Mar 31, 2026	20-F
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$10.93M	December 2025	Mar 31, 2026	20-F
Total assetsAssets	$32.72M	December 2025	Mar 31, 2026	20-F
Total liabilitiesLiabilities	$6.74M	December 2025	Mar 31, 2026	20-F

New filings

Explore methodology ↗